Modera Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Modera Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.27M	Buy	20,658 +23	+0.1%	+$3.11K	0.03%	229
2026 Q1	$2.64M	Sell	20,635 -382	-2%	-$47.7K	0.03%	233
2025 Q4	$2.56M	Sell	21,017 -120	-0.6%	-$13.8K	0.03%	242
2025 Q3	$2.12M	Sell	21,137 -259	-1%	-$23.3K	0.02%	258
2025 Q2	$1.77M	Sell	21,396 -1,384	-6%	-$110K	0.02%	267
2025 Q1	$1.85M	Buy	22,780 +1,014	+5%	+$90.6K	0.03%	252
2024 Q4	$1.96M	Sell	21,766 -1,723	-7%	-$167K	0.02%	250
2024 Q3	$2.32M	Buy	23,489 +2,975	+15%	+$292K	0.03%	221
2024 Q2	$1.9M	Sell	20,514 -248	-1%	-$22.2K	0.03%	226
2024 Q1	$1.97M	Hold	20,762	–	–	0.03%	229
2023 Q4	$1.85M	Sell	20,762 -322	-2%	-$23.9K	0.03%	230
2023 Q3	$1.54M	Sell	21,084 -769	-4%	-$61.4K	0.03%	239
2023 Q2	$1.82M	Buy	+21,853	New	+$1.83M	0.03%	232
2022 Q4	–	Sell	-2,801	Closed	-$222K	–	362
2022 Q3	$222K	Hold	2,801	–	–	0.01%	288
2022 Q2	$208K	Hold	2,801	–	–	0.01%	314
2022 Q1	$252K	Hold	2,801	–	–	0.01%	313
2021 Q4	$314K	Sell	2,801 -168	-6%	-$20.3K	0.01%	390
2021 Q3	$373K	Hold	2,969	–	–	0.02%	178
2021 Q2	$402K	Buy	2,969 +181	+6%	+$23.8K	0.02%	161
2021 Q1	$378K	Buy	2,788 +186	+7%	+$27.8K	0.02%	160
2020 Q4	$366K	Buy	2,602 +22	+0.9%	+$2.82K	0.03%	157
2020 Q3	$288K	Sell	2,580 -46	-2%	-$5.16K	0.04%	126
2020 Q2	$294K	Sell	2,626 -336	-11%	-$33.1K	0.05%	121
2020 Q1	$229K	Buy	2,962 +150	+5%	+$13.3K	0.05%	129
2019 Q4	$267K	Hold	2,812	–	–	0.04%	120
2019 Q3	$214K	Sell	2,812 -170	-6%	-$14.1K	0.04%	135
2019 Q2	$262K	Hold	2,982	–	–	0.05%	117
2019 Q1	$270K	Hold	2,982	–	–	0.05%	113
2018 Q4	$214K	Hold	2,982	–	–	0.04%	126
2018 Q3	$286K	Sell	2,982 -22	-0.7%	-$2.13K	0.06%	108
2018 Q2	$286K	Sell	3,004 -165	-5%	-$15.2K	0.06%	106
2018 Q1	$278K	Buy	3,169 +302	+11%	+$27.6K	0.06%	100
2017 Q4	$243K	Hold	2,867	–	–	0.05%	111
2017 Q3	$248K	Buy	2,867 +1	+0%	+$80	0.06%	111
2017 Q2	$221K	Buy	+2,866	New	+$203K	0.05%	108
2016 Q4	–	Sell	-3,314	Closed	-$220K	–	116
2016 Q3	$220K	Buy	+3,314	New	+$205K	0.07%	100

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Modera Wealth Management's XBI Position: Q2 2026 in Review

Modera Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.11% in Q2 2026, buying an estimated $3.11K and bringing the position to 20,658 shares worth $3.27M. The position accounts for 0.03% of the portfolio, ranked #229.

Modera Wealth Management first reported a position in XBI in Q3 2016 and has held it in 36 quarters since. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Modera Wealth Management held 20,658 shares of State Street SPDR S&P Biotech ETF worth $3.27M as of Q2 2026.
Modera Wealth Management bought 23 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.11K.
State Street SPDR S&P Biotech ETF made up 0.03% of Modera Wealth Management's portfolio in Q2 2026, its #229 holding.
Modera Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and has held it in 36 quarters since.
551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Modera Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.